Leading the way to safer medication
 Crosscheck  Recommender

Bezlotoxumab

Brand names: ZINPLAVA

Therapeutic Indications

Bezlotoxumab is indicated for:

Prevention of recurrence of Clostridium difficile infection (CDI)

Irrespective of gender only Adults (18 years old or older)

Bezlotoxumab is indicated for the prevention of recurrence of Clostridium difficile infection (CDI) in adults at high risk for recurrence of CDI.

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Intravenous - 10 mg/kg once

Contraindications

Active ingredient Bezlotoxumab is contraindicated in the following cases: